Key Financial Data Of Reporting Company

COSMOS Pharmaceutical Corporation - Filing #7578936

Concept 2022-09-01 to
2022-11-30
2022-06-01 to
2022-11-30
As at
2022-11-30
2021-06-01 to
2022-05-31
As at
2022-05-31
2021-09-01 to
2021-11-30
As at
2021-11-30
2021-06-01 to
2021-11-30
Key financial data of reporting company
Business results of reporting company
Net sales
404,016,000,000 JPY
755,414,000,000 JPY
371,138,000,000 JPY
Ordinary profit (loss)
16,900,000,000 JPY
32,861,000,000 JPY
16,494,000,000 JPY
Net assets
200,226,000,000 JPY
190,507,000,000 JPY
180,147,000,000 JPY
Total assets
378,885,000,000 JPY
363,052,000,000 JPY
346,135,000,000 JPY
Basic earnings (loss) per share
121.66
285.34
584.76
126.31
283.99
Diluted earnings per share
Equity-to-asset ratio
0.528 xbrli:pure
0.525 xbrli:pure
0.520 xbrli:pure
Net cash provided by (used in) operating activities
16,848,000,000 JPY
32,194,000,000 JPY
7,069,000,000 JPY
Net cash provided by (used in) investing activities
-21,295,000,000 JPY
-43,717,000,000 JPY
-17,371,000,000 JPY
Net cash provided by (used in) financing activities
-3,240,000,000 JPY
-6,222,000,000 JPY
-3,297,000,000 JPY
Cash and cash equivalents
29,674,000,000 JPY
37,362,000,000 JPY
41,508,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.